Published in Neuropsychopharmacology on April 01, 2014
Somatostatin, neuronal vulnerability and behavioral emotionality. Mol Psychiatry (2015) 0.91
GABA interneurons mediate the rapid antidepressant-like effects of scopolamine. J Clin Invest (2016) 0.85
DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS. Depress Anxiety (2015) 0.85
Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings. Mol Psychiatry (2014) 0.84
Selective Manipulation of Neural Circuits. Neurotherapeutics (2016) 0.83
Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state. Mol Psychiatry (2016) 0.81
DREADDS: Use and application in behavioral neuroscience. Behav Neurosci (2016) 0.80
The Use of DREADDs to Deconstruct Behavior. Front Genet (2016) 0.80
Impact of anxiety on prefrontal cortex encoding of cognitive flexibility. Neuroscience (2016) 0.79
Epilepsy-Related Slack Channel Mutants Lead to Channel Over-Activity by Two Different Mechanisms. Cell Rep (2015) 0.78
Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABAA Receptor Positive Allosteric Modulator. Front Pharmacol (2016) 0.78
Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons. J Neurosci (2016) 0.77
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine. Curr Neuropharmacol (2017) 0.77
Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs. J Neurosci (2016) 0.75
Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality. Neuropsychopharmacology (2016) 0.75
Somatostatin-positive GABAergic interneuron: new targets for depression. Mol Psychiatry (2017) 0.75
Prefrontal Cortex GABAergic Deficits and Circuit Dysfunction in the Pathophysiology and Treatment of Chronic Stress and Depression. Curr Opin Behav Sci (2017) 0.75
Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms. Chronic Stress (Thousand Oaks) (2017) 0.75
Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives. Biol Psychiatry (2017) 0.75
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci (2009) 21.94
Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci (2005) 11.68
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc Natl Acad Sci U S A (2007) 7.96
A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron (2011) 6.93
Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse (2004) 5.44
Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest (2011) 5.12
Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron (2009) 4.98
Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell (1987) 4.02
Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry (2002) 3.68
Deconstruction of a neural circuit for hunger. Nature (2012) 3.62
Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization. Nat Neurosci (2010) 3.55
Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons. Nat Neurosci (2013) 3.51
Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Dev Neurobiol (2011) 3.50
Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry (2007) 3.15
Depression in older adults. Annu Rev Clin Psychol (2009) 3.07
Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci (2010) 2.84
Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry (1999) 2.78
Remote control of neuronal signaling. Pharmacol Rev (2011) 2.66
Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century. Toxicon (2001) 2.24
Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry (2000) 2.21
Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry (2005) 2.06
Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry (2009) 2.01
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry (2002) 1.99
A chemical-genetic approach to study G protein regulation of beta cell function in vivo. Proc Natl Acad Sci U S A (2009) 1.90
The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry (2010) 1.80
GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology (2006) 1.80
Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS One (2011) 1.66
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry (2011) 1.48
Recurrent network activity drives striatal synaptogenesis. Nature (2012) 1.44
Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology (2008) 1.42
Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination. Mol Cell Biol (2004) 1.40
gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol Psychiatry (2010) 1.39
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol (2011) 1.38
Genome wide gene expression studies in mood disorders. OMICS (2006) 1.35
Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.28
Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis (2011) 1.13
The logic of inhibitory connectivity in the neocortex. Neuroscientist (2012) 1.08
Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry (2005) 1.08
Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administration. Arch Int Pharmacodyn Ther (1995) 1.06
Novel designer receptors to probe GPCR signaling and physiology. Trends Pharmacol Sci (2013) 1.03
Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J Neurosci Methods (2011) 1.02
Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target? Front Pharmacol (2013) 1.02
Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci Biobehav Rev (2010) 0.99
Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders. Dialogues Clin Neurosci (2013) 0.99
Chronic reduction in inhibition reduces receptive field size in mouse auditory cortex. Proc Natl Acad Sci U S A (2012) 0.93
Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain. Neuropsychopharmacology (2012) 0.91
Resilient emotionality and molecular compensation in mice lacking the oligodendrocyte-specific gene Cnp1. Transl Psychiatry (2011) 0.84
Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiol Behav (2011) 0.82
Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression. Neuropsychopharmacology (2014) 0.81